Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grutzmacher & Lewis, operating as Sacramento Eye Consultants, is a premier ophthalmology practice and clinical research center based in Sacramento, California. The firm specializes in advanced medical and surgical eye care, with a particular focus on glaucoma, cataracts, corneal disorders, and refractive surgery. Beyond its clinical operations, the practice is a significant site for ophthalmic clinical research, participating in numerous Phase 1 through Phase 4 trials for major pharmaceutical and biotechnology companies. The organization is led by internationally recognized experts, including co-founder Dr. Richard A. Lewis, a pioneer in micro-invasive glaucoma surgery (MIGS) and a frequent consultant for ophthalmic drug development. By integrating high-level clinical expertise with a robust research infrastructure, Grutzmacher & Lewis provides patients with access to cutting-edge therapies and contributes to the advancement of vision science globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grutzmacher & Lewis.